- Report
- March 2024
- 180 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- February 2024
- 122 Pages
Global
From €2883EUR$2,990USD£2,465GBP
- Clinical Trials
- April 2024
- 110 Pages
Global
From €1928EUR$2,000USD£1,649GBP
- Report
- January 2024
- 200 Pages
Global
From €4001EUR$4,150USD£3,422GBP
- Report
- March 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- March 2024
- 186 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- February 2021
- 345 Pages
Global
From €3615EUR$3,750USD£3,092GBP
- Report
- April 2023
- 115 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- January 2022
- 200 Pages
Global
From €7231EUR$7,500USD£6,184GBP
- Report
- January 2022
- 60 Pages
Global
From €3808EUR$3,950USD£3,257GBP
- Report
- November 2021
- 109 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- February 2021
- 33 Pages
Global
€1271EUR$1,318USD£1,087GBP
- Report
- August 2022
United States
From €1870EUR$1,940USD£1,600GBP
- Report
- August 2022
Global
From €762EUR$790USD£651GBP
- Report
- August 2021
Global
From €3847EUR$3,990USD£3,290GBP
- Report
- August 2021
Europe
From €3297EUR$3,420USD£2,820GBP
- Report
- February 2021
Global
From €2854EUR$2,960USD£2,441GBP
- Drug Pipelines
- July 2020
- 156 Pages
Global
From €1928EUR$2,000USD£1,649GBP
- Report
- February 2024
- 81 Pages
Global
From €3500EUR$3,889USD£3,098GBP
The Erectile Dysfunction Drug market is a subset of the Sexual and Reproductive Health Drugs market. These drugs are used to treat erectile dysfunction, a condition in which a man is unable to achieve or maintain an erection sufficient for sexual intercourse. Common treatments include phosphodiesterase type 5 inhibitors, such as sildenafil, tadalafil, and vardenafil, as well as testosterone replacement therapy. These drugs are typically prescribed by a doctor and can be taken orally or injected directly into the penis.
The Erectile Dysfunction Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Pfizer, Eli Lilly, Bayer, Merck, and GlaxoSmithKline. Other companies include Teva Pharmaceuticals, Sun Pharmaceuticals, and Cipla. Show Less Read more